Add to watchlist
Back

 

21470-01 - Lecture: Pharmacogenomics 1 CP

Semester spring semester 2021
Course frequency Every spring sem.
Lecturers Josef Gut (joseph.gut@unibas.ch, Assessor)
Content Basics Genetic polymorphisms; allelic variants; haplotypes; genotypes; phenotypes; allelic frequencies; ethnic group frequencies: Odds-ratio; positive predictive factors; negative predictive factors; genome-wide association studies; expression priofiles; etc. Pharmaco- /Toxicogenetics Pharmacogenetics in clinical setting; personalized medicine; gene-based dosie selection/adjustement; gene-based patient selection; companion tests. Expression genetics Gene expression profiles in cellular systems; gene expression profiles in preclinical animal models; gene expression proflles in the clinical staging of diseases and/or disease outcome under selected therapy regimen; realization of diagnostic tests.
Learning objectives The students understand the basic principles of pharmaco- and toxicogenomics. They also understand the concepts of pharmaco- and toxicogenetics and of expression genetics. The students understand the meaning of the correlation of genotype (or haplotype) and phenotype and corresponding tests aiming at optimizing of drug therapies. The students know a selection of important genes (and their most frequent allelic variants) which play major roles as efficacy targets for selected therapies, as targets of impaired drug disposition, and as targets for predispositions of patients for serious adverse drug effects. The students understand the meaning of expression profiles and, based on selected examples, the use of such profiles in the preclinical and clinical development of drugs as well as in the prediction of disease progression and/or therapy outcomes. The students understand the meaning of selected alleles and/or their expressed protein variants as biomarkers and their usage in as diagnostics in the approval process of new therapeutics.
Bibliography Will be announced at the beginning of the course
Comments Power-Point Folien der Vorlesung werden auf der Webseite der Abteilung für Molekular- und Systemtoxikologie zugänglich sein.
Film and sound recordings during the course are strictly forbidden (recorders may be confiscated

 

Admission requirements Completed Bachelor degree
Language of instruction English
Use of digital media No specific media used

 

Interval Weekday Time Room
wöchentlich Wednesday 15.15-17.00 - Online Präsenz -

Dates

Date Time Room
Wednesday 03.03.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 10.03.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 17.03.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 24.03.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 31.03.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 07.04.2021 15.15-17.00 - Online Präsenz -, --
Wednesday 14.04.2021 15.15-17.00 - Online Präsenz -, --
Modules Electives Master Science in Pharmacy: Recommendations (Master's Studies: Science in Pharmacy)
Module: Translating Pharmacology and Drug Safety to Humans (Master's Studies: Drug Sciences)
Assessment format continuous assessment
Assessment details Group work and online presentations (details will be communicated during the lecture).
Assessment registration/deregistration Reg.: course registration, dereg: cancel course registration
Repeat examination no repeat examination
Scale Pass / Fail
Repeated registration as often as necessary
Responsible faculty Faculty of Science, studiendekanat-philnat@unibas.ch
Offered by Departement Pharmazeutische Wissenschaften

Back